Oligonucleotide Regulatory Affairs and Challenges

Considerations and requirements for taking an oligonucleotide therapeutic, synthesized with innovative sustainable processes, from the laboratory to clinical trials are discussed considering the regulatory aspects related to impurities and to the preparation of dossiers.